Regresa al Registro Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorShitara, Kohei
dc.contributor.authorDoi, Toshihiko
dc.contributor.authorHosaka, Hisashi
dc.contributor.authorThuss-Patience, Peter
dc.contributor.authorSantoro, Armando
dc.contributor.authorLongo-Muñoz, Federico
dc.contributor.authorAlsina Maqueda, Maria
dc.date.accessioned2022-09-09T07:12:40Z
dc.date.available2022-09-09T07:12:40Z
dc.date.issued2022-05
dc.identifier.citationShitara K, Doi T, Hosaka H, Thuss-Patience P, Santoro A, Longo F, et al. Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS). Gastric Cancer. 2022 May;25:586–97.
dc.identifier.issn1436-3305
dc.identifier.urihttp://hdl.handle.net/11351/8082
dc.descriptionGrupos de edad; Neoplasias gastrointestinales; Trifluridina
dc.language.isoeng
dc.publisherSpringer
dc.relation.ispartofseriesGastric Cancer;25
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectEsòfag - Càncer - Tractament
dc.subjectQuimioteràpia combinada
dc.subject.meshEsophageal Neoplasms
dc.subject.mesh/drug therapy
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols
dc.titleEfficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS)
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1007/s10120-021-01271-9
dc.subject.decsneoplasias del esófago
dc.subject.decs/farmacoterapia
dc.subject.decsprotocolos de quimioterapia antineoplásica combinada
dc.relation.publishversionhttps://doi.org/10.1007/s10120-021-01271-9
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Shitara K, Doi T] Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa-shi, Japan. [Hosaka H] Department of Gastroenterology, Gunma Prefectural Cancer Center, Ota, Gunma, Japan. [Thuss-Patience P] Medizinische Klinik m.S. Hämatologie, Onkologie und Tumorimmunologie, Charité-Universitätsmedizin Berlin, Berlin, Germany. [Santoro A] Department of Biomedical Sciences, Humanitas University, Milan, Italy. IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy. [Longo F] Medical Oncology, Hospital Universitario Ramon y Cajal, IRYCIS, CIBERONC, Madrid, Spain. [Alsina M] Servei d’Oncologia Mèdica, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
dc.identifier.pmid34997449
dc.identifier.wos000740186000001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Regresa al Registro Simple